Timing of CSF Biomarker Divergence for Alzheimer Disease, Normal Cognition Varies
WEDNESDAY, Feb. 21, 2024 -- Cerebrospinal fluid (CSF) and other biomarkers differ for individuals with Alzheimer disease and cognitively normal controls, with the estimated times of divergence varying from 18 to six years before diagnosis,...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news
More News: Alzheimer's | Pharmaceuticals